Streetbeat News

Stock Prices

GGR

Gogoro Inc (NASDAQ:GGR) reported a 3.8% decline in Q2 FY23 sales to $87.25 million due to lower scooter sales in Taiwan. However, battery swapping revenue grew by 9.6% to $33.3 million. The company's gross margin expanded to 15.2% and the operating loss narrowed to $20.3 million. Gogoro lowered its FY23 revenue outlook from $400 million - $450 million to $340 million - $370 million due to soft demand in Taiwan and the timing of international projects.

Portfolio Pulse from Shivani Kumaresan

August 10, 2023 | 3:37 pm

MSFT

XELA

Exela Technologies (XELA) announced a collaboration with Microsoft (MSFT) to allow customers to leverage generative AI technologies on Microsoft Azure. The collaboration, initially focused on India, combines Exela technology with Microsoft Azure OpenAI Service. Despite the announcement, XELA shares are trading lower on above-average trading volume.

Portfolio Pulse from Erica Kollmann

August 10, 2023 | 3:35 pm

RBLX

Roblox Corp (RBLX) shares rose in early trading after a previous session's drop due to a revenue miss. Analysts from Morgan Stanley, Needham, Stifel, Benchmark, and Roth Capital Markets provided mixed reviews on the company's Q2 results and future prospects. While some analysts upgraded their ratings and raised price targets, others maintained their ratings but reduced price targets. The market cap correction of $5bn was deemed 'excessive' by Roth Capital Markets.

Portfolio Pulse from Priya Nigam

August 10, 2023 | 3:34 pm

GDRX

GoodRx Holdings Inc (NASDAQ:GDRX) reported better-than-expected Q2 results with sales of $189.7 million, beating the consensus of $186.82 million. The company revised its FY23 sales guidance to $750-$760 million. Following the earnings announcement, several analysts including Wells Fargo, RBC Capital, Credit Suisse, Goldman Sachs, and Evercore ISI Group raised their price targets on GoodRx. The company's shares gained 7.2% to trade at $8.52 on Thursday.

Portfolio Pulse from Lisa Levin

August 10, 2023 | 3:34 pm

BABA

PDD

PDD Holdings Inc's shares are trading higher by 2.7% in sympathy with Alibaba Group Holding's better-than-expected Q1 financial results. Both companies operate in the e-commerce industry and strong results from Alibaba may imply increased consumer spending and heightened demand in the e-commerce market, which could positively impact PDD Holdings' stock.

Portfolio Pulse from Henry Khederian

August 10, 2023 | 3:34 pm

LQR

Trading of LQR House shares has resumed.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 3:32 pm

MU

A significant investor has taken a bearish stance on Micron Technology (NASDAQ:MU), with 58% of recent trades being bearish and 41% bullish. The trades range from $35.0 to $75.0, with a mean open interest of 3809.1 and a total volume of 4,320.00. Wolfe Research has downgraded its action to Outperform with a price target of $80. The current price of MU is down -0.88% at $66.11.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 3:31 pm

CSCO

A whale investor has taken a bullish stance on Cisco Systems (NASDAQ:CSCO), with 60% of investors opening trades with bullish expectations and 40% with bearish. The whale has been targeting a price range from $45.0 to $57.5 for Cisco Systems over the last 3 months. The price of CSCO is up 1.25% at $53.65. B of A Securities, JP Morgan, and Exane BNP Paribas have given price targets of $56, $62, and $45 respectively.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 3:31 pm

REGN

A significant bullish stance has been taken on Regeneron Pharmaceuticals (NASDAQ:REGN) by a large investor, as indicated by a large position in the company's options. The sentiment among these big-money traders is split 50-50 between bullish and bearish. The price target for Regeneron Pharmaceuticals, based on the volume and open interest of these contracts, ranges from $710 to $1000. Several financial institutions have maintained positive ratings on Regeneron, with price targets ranging from $820 to $950.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 3:31 pm

SGEN

Seagen (NASDAQ:SGEN) has outperformed the market over the past 15 years, producing an average annual return of 20.36%. If an investor had bought $100 of SGEN stock 15 years ago, it would be worth $1,584.52 today. The company currently has a market capitalization of $36.68 billion.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 3:30 pm